RRM2 and renal carcinoma: Numerous studies suggest that RRM2 was dysregulated in various cancers, promoting the progression of cancers, such as renal cancer, liver cancer, lung cancer, breast cancer, colon cancer, ovarian cancer and bladder cancer 15-21.